Literature DB >> 20395262

The symptom of functional weakness: a controlled study of 107 patients.

Jon Stone1, Charles Warlow, Michael Sharpe.   

Abstract

Functional weakness describes weakness which is both internally inconsistent and incongruent with any recognizable neurological disease. It may be diagnosed as a manifestation of conversion disorder or dissociative motor disorder. Other names include psychogenic or 'non-organic' paralysis. We aimed to describe the incidence, demographic and clinical characteristics of cases with functional weakness of less than 2 years duration, and to compare these with controls with weakness attributable to neurological disease. Both cases and controls were recruited from consultant neurologists in South East Scotland. Participating patients underwent detailed assessments which included: physical examination, structured psychiatric interview (Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders), measures of symptoms, disability and distress [Short Form (36) Health Survey, Hospital and Anxiety Depression Scale], and assessment of their illness beliefs using an augmented version of the Illness Perception Questionnaire. In total, 107 cases (79% female, mean age 39 years, median duration of illness 9 months) were recruited. This number suggests a minimum annual incidence of 3.9/100 000. Forty-six controls (83% female, median age 39 years, duration 11 months) were also recruited. Compared to controls, cases had similar levels of disability but more physical symptoms, especially pain. They had a higher frequency of psychiatric disorders, especially current major depression (32 versus 7%, P < 0.0001), generalized anxiety disorder (21 versus 2%, P < 0.005), panic disorder (36 versus 13%, P < 0.001) and somatization disorder (27 versus 0%, P < 0001). There was no difference in median self-rated anxiety and depression scores. Paradoxically, they were less likely than controls to agree that stress was a possible cause of their illness (24 versus 56%, P < 0.001). Cases were twice as likely as controls to report that they were not working because of their symptoms (65 versus 33%, P < 0.0005). Functional weakness is a commonly encountered clinical problem. Patients with this symptom are as disabled as patients with weakness of similar duration due to neurological disease. There is a paradox between the frequency of depression and anxiety diagnoses and the patient's willingness to accept these as potentially relevant to their symptoms. We discuss the theoretical and practical implications of these findings for the concept of conversion disorder.

Entities:  

Mesh:

Year:  2010        PMID: 20395262     DOI: 10.1093/brain/awq068

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  27 in total

1.  Psychopathology and psychogenic movement disorders.

Authors:  Sarah Kranick; Vindhya Ekanayake; Valeria Martinez; Rezvan Ameli; Mark Hallett; Valerie Voon
Journal:  Mov Disord       Date:  2011-06-28       Impact factor: 10.338

Review 2.  Conversion Disorder, Functional Neurological Symptom Disorder, and Chronic Pain: Comorbidity, Assessment, and Treatment.

Authors:  Patricia Tsui; Andrew Deptula; Derek Y Yuan
Journal:  Curr Pain Headache Rep       Date:  2017-06

3.  A General Pediatrics and Integrative Medicine Approach to Pervasive Refusal Syndrome: A Case Report.

Authors:  Tido Von Schoen-Angerer; Elisabeth Helmschmidt; René Madeleyn; Reinhard Kindt; Christoph Möller; Gunver Sophia Kienle; Jan Vagedes
Journal:  Perm J       Date:  2016-09-02

4.  Resilience linked to personality dimensions, alexithymia and affective symptoms in motor functional neurological disorders.

Authors:  Rozita Jalilianhasanpour; Benjamin Williams; Isabelle Gilman; Matthew J Burke; Sean Glass; Gregory L Fricchione; Matcheri S Keshavan; W Curt LaFrance; David L Perez
Journal:  J Psychosom Res       Date:  2018-02-13       Impact factor: 3.006

5.  Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study.

Authors:  Michele Tinazzi; Francesca Morgante; Enrico Marcuzzo; Roberto Erro; Paolo Barone; Roberto Ceravolo; Sonia Mazzucchi; Andrea Pilotto; Alessandro Padovani; Luigi M Romito; Roberto Eleopra; Mario Zappia; Alessandra Nicoletti; Carlo Dallocchio; Carla Arbasino; Francesco Bono; Angelo Pascarella; Benedetta Demartini; Orsola Gambini; Nicola Modugno; Enrica Olivola; Vincenzo Di Stefano; Alberto Albanese; Gina Ferrazzano; Alessandro Tessitore; Maurizio Zibetti; Giovanna Calandra-Buonaura; Martina Petracca; Marcello Esposito; Antonio Pisani; Paolo Manganotti; Fabrizio Stocchi; Mario Coletti Moja; Angelo Antonini; Giovanni Defazio; Christian Geroin
Journal:  Mov Disord Clin Pract       Date:  2020-09-22

6.  Hypermobile Ehlers-Danlos Syndrome: A Prodromal Subtype of Functional Movement Disorders?

Authors:  Jason Margolesky; Dyanet Puentes; Alberto J Espay
Journal:  Mov Disord Clin Pract       Date:  2022-08-24

7.  Functional neurological symptoms masquerading as Wernicke encephalopathy following bariatric surgery.

Authors:  Andrew M Kiselica; Sabra Rosen; Jared F Benge
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-09-18

8.  A Bayesian account of 'hysteria'.

Authors:  Mark J Edwards; Rick A Adams; Harriet Brown; Isabel Pareés; Karl J Friston
Journal:  Brain       Date:  2012-05-28       Impact factor: 13.501

9.  Psychosocial interventions for conversion and dissociative disorders in adults.

Authors:  Christina A Ganslev; Ole Jakob Storebø; Henriette E Callesen; Rachel Ruddy; Ulf Søgaard
Journal:  Cochrane Database Syst Rev       Date:  2020-07-17

Review 10.  Neuroinflammation, neuroautoimmunity, and the co-morbidities of complex regional pain syndrome.

Authors:  Mark S Cooper; Vincent P Clark
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-25       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.